Regeneus Ltd. is regenerative medicine company. It develops and commercializes innovative cell-based therapies to address unmet medical needs in human and veterinary health. The company was founded by Ben Herbert and Graham Vesey on August 14, 2007 and is headquartered in Pymble, Australia.
|Market Price at 22-11-2017||$0.12|
|Price to Earnings Ratio||7.82|
|Market Capitalisation||$25.07 (million)|
|Return on Equity (ROE)||41.23%|